1,660
Participants
Start Date
December 14, 2018
Primary Completion Date
May 17, 2023
Study Completion Date
May 24, 2023
MenACYW conjugate vaccine
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine, 0.5 mL, intramuscular
Meningococcal group A, C, W-135, and Y conjugate vaccine
Meningococcal group A, C, W-135, and Y conjugate vaccine, 0.5 mL, intramuscular
DTaP-IPV-HB-Hib vaccine
Diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b vaccine
Pneumococcal vaccine (13-valent)
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)
Pneumococcal vaccine (10-valent)
Pneumococcal polysaccharide conjugate vaccine (10-valent, adsorbed)
MMR vaccine
Measles, mumps, and rubella vaccine
Investigational Site Number : 7245001, Santiago de Compostela
Investigational Site Number : 3803002, Milan
Investigational Site Number : 2462008, Turku
Investigational Site Number : 6424001, Bucaresti
Investigational Site Number : 7245003, Madrid
Investigational Site Number : 7245002, Madrid
Investigational Site Number : 2462002, Pori
Investigational Site Number : 2462010, Tampere
Investigational Site Number : 2031013, Domažlice
Investigational Site Number : 7245006, Seville
Investigational Site Number : 2462009, Seinäjoki
Investigational Site Number : 2462006, Kokkola
Investigational Site Number : 2462005, Oulu
Investigational Site Number : 6424006, Caracal
Investigational Site Number : 6424003, Brasov
Investigational Site Number : 6424002, Călăraşi
Investigational Site Number : 2031006, Chlumec nad Cidlinou
Investigational Site Number : 2031010, Jindřichův Hradec
Investigational Site Number : 2031012, Jindřichův Hradec
Investigational Site Number : 2031003, Ostrava
Investigational Site Number : 2031008, Ostrava-hrabuvka
Investigational Site Number : 2031009, Pardubice
Investigational Site Number : 2031005, Pardubice
Investigational Site Number : 2031007, Smiřice
Investigational Site Number : 2462007, Espoo
Investigational Site Number : 2462003, Helsinki
Investigational Site Number : 2462004, Helsinki
Investigational Site Number : 2462001, Järvenpää
Investigational Site Number : 6167002, Bydgoszcz
Investigational Site Number : 6167004, Trzebnica
Investigational Site Number : 6167003, Siemianowice Śląskie
Investigational Site Number : 6167006, Torun
Investigational Site Number : 7526001, Umeå
Sanofi Pasteur, a Sanofi Company
INDUSTRY